Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid.
about
Nitric oxide and peroxynitrite in health and diseaseSOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathwaysNitro-Arachidonic Acid Prevents Angiotensin II-Induced Mitochondrial Dysfunction in a Cell Line of Kidney Proximal Tubular CellsSuperoxide dismutase mimics: chemistry, pharmacology, and therapeutic potentialRational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure.Nitroarachidonic acid prevents NADPH oxidase assembly and superoxide radical production in activated macrophagesA combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itselfTherapeutic potential of peroxynitrite decomposition catalysts: a patent review.Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications.Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation.New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.A manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocin-diabetic rats.New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme.Unconventional neuroprotection against Ca2+ -dependent insults by metalloporphyrin catalytic antioxidants.Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes.
P2860
Q24645400-9360AAA3-F020-4FDD-A781-47B3153DC55DQ28385000-23670D9F-F919-407E-868B-5B9ACED05038Q28550560-95056EC9-416F-430E-8B8D-0CD31FE46AF6Q34110107-A86C8E07-6475-432D-8B64-8A7D8CED4238Q34455737-A77C7C18-F355-446C-A29A-9D2F1BCF7979Q35349280-5B1FF6F0-1584-4EE9-8D7A-A617A68F1F50Q36142224-27922FB4-D485-4D20-B908-68FC14697B62Q36756122-1C48A3DA-D72D-4013-9A18-AE9C0CED7381Q36839447-8CF47926-D0C8-48CA-8BD0-6AB429B0F6F9Q36961432-B1C7176C-4F49-406A-B7E1-09FE2CCD75B7Q38313367-9E51B795-FBA9-40E0-93F2-AA6DBCC47FC7Q40655619-CB534F7F-9766-4E6B-9808-20837BD300EFQ41876611-ACDDC5F3-B737-4BCB-9CB0-3B67DF1CE0D5Q42074579-1209DE40-B2C6-46FD-B9FD-52D886F8BC8AQ44977419-663EA077-ACF7-44C1-AA2D-34D5A4FDA61EQ46473709-13E9C4EF-CB9D-4E92-BD98-B9F20A67877DQ46886493-89CDF715-8B3B-4036-AD66-8342E76A587DQ48452275-51A02A01-1EE3-4DD8-BBBF-FBFCD2CCE532Q53575481-ECEB7790-CA03-427B-ABF1-34156988E9A1
P2860
Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@en
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@nl
type
label
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@en
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@nl
prefLabel
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@en
Peroxynitrite flux-mediated LD ...... in the presence of uric acid.
@nl
P2093
P50
P1476
Peroxynitrite flux-mediated LD ...... s in the presence of uric acid
@en
P2093
Homero Rubbo
Horacio Botti
Ines Batinić-Haberle
Rafael Radi
P304
P356
10.1016/J.FREERADBIOMED.2003.07.004
P577
2003-11-01T00:00:00Z